Animals carcinogen

At the same time the FDA was attempting to deal with DES residues, the agency also recognized the fundamental strangeness of the no residue requirement. In effect, it said that if a carcinogenic animal drug could not be detected in food, the food was to be considered safe. This is odd, because it defines safety in terms of the capabilities of analytical chemistry. It is not only odd, it makes no sense whatsoever. Our ability to detect chemicals in the environment bears no relationship whatsoever to the health risks they pose. 

Anterior uveitis and neutropenia are fairly common side effects of cidofovir therapy. Ocular hypotony and metabolic acidosis are rare. Exposure to therapeutic levels of cidofovir causes cancer in rats therefore, this drug should be considered a potential human carcinogen. Animal studies have also shown cidofovir to produce embryotoxic and teratogenic effects and to impair fertility. 

Carbaryl Tremors, convulsions, ataxia, nausea, vomiting, excessive salivation, bronchial secretions, dyspnea, lacrimation, teratogenicity Carcinogen (animal, suspected)... 

Dieldrin CNS effects (tremors convulsions, coma), nausea, vomiting Carcinogen (animal positive), liver damage (glycogen depletion, fatty infiltration, necrosis), kidney damage (fatty changes, necrosis)... 

OSHA PEL TWA 2 ppm ACGIH TLV TWA 10 ppm Suspected Human Carcinogen Animal Carcinogen DFG MAK 10 ppm (50 mg/m ) Confirmed Animal Carcinogen with Unknown Relevance to Humans)... 

TLV-TWA 0.1 mg/m (ACGIH 1989) carcinogenicity Animal Inadequate Evidence (lARC). 

TLV-TWA 0.1 mg/m (ACGIH 1989) TWA skin 0.1 mg/m (MSHA and OSHA) IDLH 25 mg/m (NIOSH) carcinogenicity Animal Inadequate Evidence (lARC). 

Carcinogenicity Animal Sufficient Evidence (lARC) no TWA assigned (because it is a carcinogen, there should be no exposure to this compound). 

No exposure limit is set for this compound. Carcinogen — Animal Limited Evidence (lARC). 

TLV-TWA 2 ppm ( 11 mg/m ) (ACGIH), 5 ppm (MSHA and OSHA) carcinogenicity Animal Limited Evidence (lARC), Suspected Human Carcinogen. 

No exposure limit has been set for this compound. Carcinogenicity Animal Sufficient Evidence, Human Limited Evidence (IARC). 

Mild irritant acute oral toxicity in animals very low oral LD50 value (rats) 7000 mg/kg carcinogenic to animals oral administration caused blood and liver tumors in mice and rats carcinogenicity animal limited evidence, no evidence in humans. 

Hydrazine is a suspected carcinogen. Animal studies indicate sufficient evidence of its carcinogenicity. Administration of this compound by inhalation, oral, and intravenous routes caused tumors in the blood and lung in laboratory animals. There is, however, no evidence of any carcinogenic action of this compound in humans. 

Note 1 Warning—Poison. May be fatal if swallowed or inhaled. A known carcinogen (animal poative). 

Note S Warning— Harmful if inhaled or swallowed. Carcinogen (animal positive). Skin and eye irritant. May produce toxic vapors if burned. 

---